Fatty acid oxidation in cardiac and skeletal muscle mitochondria is unaffected by deletion of CD36
- 15 November 2007
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 467 (2) , 234-238
- https://doi.org/10.1016/j.abb.2007.08.020
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Diabetes or peroxisome proliferator-activated receptor α agonist increases mitochondrial thioesterase I activity in heartJournal of Lipid Research, 2007
- Activation of a novel long-chain free fatty acid generation and export system in mitochondria of diabetic rat heartsAmerican Journal of Physiology-Cell Physiology, 2006
- Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptinAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- A targeted proteomic approach for the analysis of rat liver mitochondrial outer membrane proteins with extensive sequence coverageAnalytical Biochemistry, 2006
- Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidationAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exerciseThe Journal of Physiology, 2006
- A Novel Function for Fatty Acid Translocase (FAT)/CD36Journal of Biological Chemistry, 2004
- Fatty Acid Translocase/CD36 Deficiency Does Not Energetically or Functionally Compromise Hearts Before or After IschemiaCirculation, 2004
- CD36 Mediates the Cardiovascular Action of Growth Hormone-Releasing Peptides in the HeartCirculation Research, 2002
- Preservation of Cardiolipin Content During Aging in Rat Heart Interfibrillar MitochondriaThe Journals of Gerontology: Series A, 2002